A prototype obesity drug called STO 609 does just that and Dr Mills thinks it could be modified to treat prostate cancer which affects 36,000 men in Britain.
A prototype obesity drug called STO 609 does just that and Dr Mills thinks it could be modified to treat prostate cancer which affects 36, 000 men in Britain.